IOVANCE BIOTHERAPEUTICS REPORTS RECORD SECOND QUARTER 2026 REVENUE OF ~$99M, BUSINESS ACHIEVEMENTS, AND CORPORATE UPDATES

Reuters · 1d ago

Please log in to view news